Abstract:The ability of C1 to bind to the Fc5mu-fragment of a monoclonal IgM was determined by means of a haemolytic C1-inhibition assay. Fc5mu fragments were produced by trypsin digestion at five different temperatures ranging from 54-62 degrees (2 degrees increments) and were purified by immunoadsorption through a column of monospecific anti-Fabmu and by molecular exclusion chromatography. Analytical ultracentrifugation showed the final preparations to be free of aggregates. A plot of mug Fc5mu required to inhibit 50% of available C1 versus temperatures of production of the fragment yielded a curve with a minimum at 58-60 degrees. Upon mild reduction and alkylation of these Fc5mu fragments their C1-fixing capacity became approximately the same irrespective of temperature of production. Fc5mu was also prepared at 25 degrees in the presence of 5 M urea, purified by immunoadsorption as before and aliquots then exposed to temperatures ranging from 40-70 degrees (5 degrees increments) for 15 min. After aggregates had been removed by chromatography a similar minimum in C1-fixation was again observed at 60 degrees. Reduction and alkylation once more abolished these differences. Fc5mu and its reduced and alkylated subunits, produced at 60 degrees and then exposed to various concentrations of urea (0-7 M) for 24 hd did not yield a minimum in C1 fixation. Reduced and alkylated Fcmu incubated at various temperatures (40-70 degrees) also did not fix C1 differentially. Examination in the near and far u.v. region of the circular dichroism spectra of different Fc5mu preparations showed a gradual loss of structure associated with restricted aromatic chromophores and secondary (beta) structure with increased temperature. Urea denaturation had a more pronounced and irreversible effect on Fc5 mu conformation. These changes could not be correlated with the CU-fixation patterns observed. It would therefore appear that elevated temperatures induce a static change in the pentameric FC-part of IgM which in turn directly influences or modulates the availability of the C1-binding site. The importance of disulphide bonds in maintaining these temperature-induced changes in Fc5mu was also indicated.

The importance of quaternary structure in the expression of the C1-binding site of IgM.

In Vitro and in Vivo Studies on As-Extruded Mg- 5.25Wt.%zn-0.6Wt.%ca Alloy As Biodegradable Metal

Microstructure, Mechanical Properties, in Vitro Degradation and Cytotoxicity Evaluations of Mg–1.5Y–1.2Zn–0.44Zr Alloys for Biodegradable Metallic Implants

Biocompatibility of magnesium-zinc alloy in biodegradable orthopedic implants

Evaluation on the corrosion resistance, antibacterial property and osteogenic activity of biodegradable Mg-Ca and Mg-Ca-Zn-Ag alloys

Corrosion behavior of biomedical AZ91 magnesium alloy in simulated body fluids

In Vitro Degradation Performance and Biological Response of a Mg–Zn–Zr Alloy

Enhanced antimicrobial properties, cytocompatibility, and corrosion resistance of plasma-modified biodegradable magnesium alloys

Study of in vitro wear resistance and degradation properties of self-made treated medical magnesium alloys

In vitro degradation and biocompatibility of WE43, ZK60, and AZ91 biodegradable magnesium alloys

Research Progress in Degradation Behavior of Biodegradable Medical Mg-based Alloys in Vivo and in Vitro

In Vitro and in Vivo Biodegradation and Biocompatibility of an MMT/BSA Composite Coating Upon Magnesium Alloy AZ31

The misalignment between degradation rate and mechanical integrity of Mg-Zn-Y-Nd alloy during the degradation evaluation in modified Hanks' solutions

In Vitro and in Vivo Degradation Behavior of Mg–2Sr–Ca and Mg–2Sr–Zn Alloys

Microstructure, Mechanical Properties, Corrosion Behavior and Biocompatibility of As-Extruded Biodegradable Mg–3Sn–1Zn–0.5Mn Alloy

Optimization of the in Vitro Biodegradability, Cytocompatibility, and Wear Resistance of the AZ31B Alloy by Micro-Arc Oxidation Coatings Doped with Zinc Phosphate

Study on mechanical and degradation behavior of Zn–Mn-xMg alloys under coupling effects of stress and SBF

Fingolimod: A Novel Immunosuppressant for Multiple Sclerosis

Design of magnesium alloys with controllable degradation for biomedical implants: From bulk to surface

Enhanced Mechanical Properties, Corrosion Resistance, Cytocompatibility, Osteogenesis, and Antibacterial Performance of Biodegradable Mg‐2Zn‐0.5Ca‐0.5Sr/Zr Alloys for Bone‐Implant Application

Potential of Biodegradable Magnesium Alloys for Medical Applications